Chemoinformaics analysis of Schisanwilsonin N
| Molecular Weight | 498.572 | nRot | 6 |
| Heavy Atom Molecular Weight | 464.3 | nRig | 24 |
| Exact Molecular Weight | 498.225 | nRing | 4 |
| Solubility: LogS | -5.572 | nHRing | 1 |
| Solubility: LogP | 3.98 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 75.847 |
| nHD | 0 | BPOL | 47.129 |
| QED | 0.382 |
| Synth | 4.062 |
| Natural Product Likeliness | 2.149 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.766 |
| MDCK | 0.0000202 |
| BBB | 0.02 |
| PPB | 0.849337 |
| VDSS | 0.932 |
| FU | 0.0748618 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.983 |
| CYP2c19-inh | 0.978 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.954 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.945 |
| CYP3a4-sub | 0.923 |
| CL | 6.316 |
| T12 | 0.112 |
| hERG | 0.056 |
| Ames | 0.066 |
| ROA | 0.037 |
| SkinSen | 0.105 |
| Carcinogencity | 0.07 |
| EI | 0.086 |
| Respiratory | 0.258 |
| NR-Aromatase | 0.787 |
| Antiviral | Yes |
| Prediction | 0.904248 |